23andMe Wins FDA Approval for New Genetic Test

23andMe Wins FDA Approval for New Genetic Test »

4 Mar, 2015
News
In the past, the FDA has expressed worry that consumers might misinterpret at-home genetic tests, leading to improper decisions without physician guidance. This is why 23andMe was forced table one of their personal genome tests in November 2013. It's been an uphill battle, 23andMe's leaders say. That's also why, when the FDA granted direct-to-consumer marketing rights for 23andMe’s Bloom Syndrome…
Ask the Experts: Developments in Genetic Testing

Ask the Experts: Developments in Genetic Testing »

There's some controversial discussion happening over on Medstro's NEJM Group Open Forum: Ask the Authors & Experts, and it's all about genetics - GINA, the Genetic Information Nondiscrimination Act, in particular. The authors of a recent NEJM article on GINA tell us that the act was designed “to fully protect the public from discrimination” and also to “allay…

Send this to a friend